Autres langues 3SBio Inc. BOERSE MUENCHEN

Actions

83B

KYG8875G1029

Temps réel BOERSE MUENCHEN Autres places de cotation 14:13:00 17/07/2024			Varia. 5j.	Varia. 1 janv.
0,785 ^EUR	0,00%		+3,97%	-7,65%

25/06	3Sbio Inc. déclare un dividende final pour l'exercice clos le 31 décembre 2023, payable le 5 août 2024	CI
25/06	3Sbio Inc. annonce des changements au sein de son conseil d'administration	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

3Sbio Inc. Declares Final Dividend for the Year Ended 31 December 2023, Payable on 5 August 2024	25/06
3Sbio Inc. Announces Board Changes	25/06
3SBIO Unit to Cooperate on Development, Sale of Weight Management Injection	29/05
3Sbio Inc. Announces Board and Committee Changes	22/04
3SBIO Gets China Nod for Use of Cancer Injection in Children with Thrombocytopenia	15/04
3SBio Inc. Approves Recombinant Human Thrombopoietin Injection for Pediatric ITP Indication	12/04
3SBio Inc. commences an Equity Buyback for 243,892,041 shares, representing 10% of its issued share capital, under the authorization approved on June 20, 2023.	27/03
3SBio's 2023 Profit Falls 19%, EPS Misses Estimates	21/03
3SBio Inc. Proposes Final Dividend for the Year Ended 31 December 2023, Payable on August 05, 2024	20/03
3SBio Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	20/03
China's NMPA Gives 3SBio Permission to Sell Anti-Dandruff Product	08/01
Mandi Foam of 3SBio Inc. Approves for Market Launch	08/01
Venus Medtech Names Former 3SBio Finance Chief as CFO	04/01
3SBio Secures Exclusive License to CStone's Anti-Tumor Drug in China	02/11
3SBio's H1 Attributable Profit Rises, Beats EPS Estimates	25/08/23
3SBio announces 2023 interim results, with revenue growing over 20% year on year and pipeline value constantly enhanced	25/08/23
3SBio : 2023 Interim Results Presentation	24/08/23
3SBio Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	24/08/23
3SBio Hires Former JPMorgan Exec as CFO	31/07/23
3Sbio Inc. Announces Appointment of He Xiang as Chief Financial Officer	28/07/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues 3SBio Inc. BOERSE MUENCHEN

Actions

83B

KYG8875G1029

Autres langues

Filtres